APA (7th ed.) Citation

D, F., CA, G., KP, F., T, C., A, T., N, K., & R, S. (2022). Assessment of Insulin Infusion Requirements in COVID-19-Infected Patients With Diabetic Ketoacidosis. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 28(8), 787. https://doi.org/10.1016/j.eprac.2022.05.006

Chicago Style (17th ed.) Citation

D, Farzadfar, Gordon CA, Falsetta KP, Calder T, Tsegaye A, Kohn N, and Schulman-Rosenbaum R. "Assessment of Insulin Infusion Requirements in COVID-19-Infected Patients With Diabetic Ketoacidosis." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 28, no. 8 (2022): 787. https://doi.org/10.1016/j.eprac.2022.05.006.

MLA (9th ed.) Citation

D, Farzadfar, et al. "Assessment of Insulin Infusion Requirements in COVID-19-Infected Patients With Diabetic Ketoacidosis." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 28, no. 8, 2022, p. 787, https://doi.org/10.1016/j.eprac.2022.05.006.